Treatment of obsessive-compulsive disorder: Personal follow-up of a 10-year material from an outpatient region medical center. Obsessive-compulsive disorder: A 3-yr prospective follow-up study of individuals treated with serotonin reuptake inhibitors OCD follow-up study. J Psychiatr Res. 2006;40:502C10. [PubMed] [Google Scholar] 53. Olsen T, Mais AH, Bilet T, Martinsen EW. Treatment of obsessive-compulsive disorder: Personal follow-up of a 10-year material from an outpatient region medical center. Nord J Psychiatry. 2008;62:39C45. [PubMed] [Google Scholar] 54. Whittal ML, Robichaud M, Thordarson DS, McLean PD. Group and individual treatment of obsessive-compulsive disorder using cognitive therapy and exposure plus response prevention: A 2-yr follow-up of two randomized tests. J Consult Clin Psychol. 2008;76:1003C14. [PubMed] [Google Scholar] 55. Reddy YC, Alur AM, Manjunath S, Kandavel T, Math SB. Long-term follow-up study of individuals with serotonin reuptake inhibitor-nonresponsive obsessive-compulsive disorder. J Clin Psychopharmacol. 2010;30:267C72. [PubMed] [Google Scholar] 56. Braga DT, Manfro GG, Niederauer K, Cordioli AV. Full remission and relapse of obsessive-compulsive symptoms after cognitive-behavioral group therapy: A two-year follow-up. Braz J Psychiatr. 2010;32:164C8. [PubMed] [Google Scholar] 57. Cabedo E, Belloch Oxytetracycline (Terramycin) A, Carri C, Larsson C, Fernndez-Alvarez H, Garca F, et al. Group versus individual cognitive treatment for obsessive-compulsive disorder: Changes in severity at post-treatment and one-year follow-up. Behav Cogn Psychother. 2010;38:227C32. [PubMed] [Google Scholar] 58. Anholt GE, Aderka IM, vehicle Balkom AJ, Smit JH, Hermesh H, de Haan E, et al. The effect of major depression on the treatment of obsessive-compulsive disorder: Results from a 5-yr follow-up. J Affect Disord. 2011;135:201C7. [PubMed] [Google Scholar] 59. Anand N, Sudhir PM, Math SB, Thennarasu K, Janardhan Reddy YC. Cognitive behavior therapy in medication non-responders with obsessive-compulsive disorder: A prospective 1-yr follow-up study. J Panic Disord. 2011;25:939C45. [PubMed] [Google Scholar] 60. Marcks BA, Weisberg RB, Dyck I, Keller MB. Longitudinal course of obsessive-compulsive disorder in individuals with panic disorders: A 15-yr prospective follow-up study. Compr Psychiatry. 2011;52:670C7. [PMC free article] [PubMed] [Google Scholar] 61. Jakubovski E, Diniz JB, Valerio C, Fossaluza V, Belotto-Silva C, Gorenstein C, et al. Clinical predictors of long-term end result in obsessive-compulsive disorder. Depress Panic. 2013;30:763C72. [PubMed] [Google Scholar] 62. Bloch MH, Green C, Kichuk SA, Dombrowski PA, Wasylink S, Billingslea E, et al. Long-term end result in adults with obsessive-compulsive disorder. Depress Panic. 2013;30:716C22. [PMC free article] [PubMed] [Google Scholar] 63. Eisen JL, Sibrava NJ, Boisseau CL, Mancebo MC, Stout RL, Pinto A, et al. Five-year course of obsessive-compulsive disorder: Predictors of remission and relapse. J Clin Psychiatry. 2013;74:233C9. [PMC free article] [PubMed] [Google Scholar] 64. Cherian AV, Math SB, Kandavel T, Reddy YC. A 5-yr prospective follow-up study of individuals with obsessive-compulsive disorder treated with serotonin reuptake Rabbit Polyclonal to RNF111 inhibitors. J Affect Disord. 2014;152-154:387C94. [PubMed] [Google Scholar] 65. Cherian AV, Pandian D, Bada Math S, Kandavel T, Janardhan Reddy YC. Family accommodation of obsessional symptoms and naturalistic end result of obsessive-compulsive disorder. Psychiatry Res. 2014;215:372C8. [PubMed] [Google Scholar] 66. Moritz S. A review on quality of life and major depression in obsessive-compulsive Oxytetracycline (Terramycin) disorder. CNS Oxytetracycline (Terramycin) Spectr. 2008;13:16C22. [PubMed] [Google Scholar] 67. Foa EB, Simpson HB, Liebowitz MR, Capabilities MB, Rosenfield D, Cahill SP, et al. Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder. J Clin Psychiatry. 2013;74:464C9. [PMC free article] [PubMed] [Google Scholar] 68. Moritz S, Rufer M, Fricke S, Karow A, Morfeld M, Jelinek L, et al. Quality of life in obsessive-compulsive disorder before and after treatment. Compr Psychiatry. 2005;46:453C9. [PubMed] [Google Oxytetracycline (Terramycin) Scholar] 69. Hertenstein E, Thiel N, Herbst N, Freyer T, Nissen C, Klz AK, et al. Quality of life changes following inpatient and outpatient treatment in obsessive-compulsive disorder: A study with 12 months follow-up. Ann Gen Psychiatry. 2013;12:4. [PMC free article] [PubMed] [Google Scholar] 70. Eisen JL, Pinto A, Mancebo MC, Dyck IR, Orlando ME, Rasmussen SA, et al. A 2-yr prospective follow-up study of the course of obsessive-compulsive disorder. J Clin Psychiatry. 2010;71:1033C9. [PMC free article] [PubMed] [Google Scholar] 71. Stewart SE, Geller DA, Jenike M, Pauls D, Shaw D, Mullin B, et al. Long-term end result of pediatric obsessive-compulsive disorder: A meta-analysis and qualitative review of the literature. Acta Psychiatr Scand. 2004;110:4C13. [PubMed] [Google Scholar] 72. Shetti CN, Reddy YC, Kandavel T, Kashyap K, Singisetti S, Hiremath AS, et al. Clinical predictors of drug nonresponse in obsessive-compulsive disorder. J Clin Psychiatry. 2005;66:1517C23. [PubMed] [Google Scholar] 73. Cherian AV, Narayanaswamy JC, Srinivasaraju R, Viswanath B, Math SB, Kandavel T, et al. Does insight have specific correlation with sign sizes in OCD? J.